CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Paid-in Capital	Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Treasury Stock	Nonredeemable Noncontrolling Interests
Balance at beginning of period (in shares) at Jan. 30, 2021			64,230,162
Balance at beginning of period at Jan. 30, 2021	$ 565,580		$ 642	$ 553,111		$ 1,034,823		$ (120,675)	$ (924,238)	$ 21,917
Balance at beginning of period (in shares) at Jan. 30, 2021									78,563,517
Increase (Decrease) in Stockholders' Equity
Net earnings	180,049					171,363				8,686
Other comprehensive income (loss), net of income tax effect	(15,840)							(14,874)		(966)
Issuance of common stock under stock compensation plans including tax effect (in shares)			718,018						739,751
Issuance of common stock under stock compensation plans including income tax effect	(751)		$ 8	(9,469)					$ 8,710
Issuance of stock under Employee Stock Purchase Plan (in shares)			38,144						38,144
Issuance of stock under Employee Stock Purchase Plan	713			263					$ 450
Share-based compensation	21,119			21,096		23
Dividends	(37,091)					(37,091)
Share repurchases (in shares)			(2,289,292)						(2,289,292)
Share repurchases	(51,030)		$ (23)	23					$ (51,030)
Noncontrolling interest capital distributions	(3,452)									(3,452)
Redeemable noncontrolling interest redemption value adjustment	(5,654)					(10,454)				4,800
Balance at end of period (in shares) at Jan. 29, 2022			62,697,032
Balance at end of period at Jan. 29, 2022	$ 653,643	$ (21,290)	$ 627	565,024	$ (43,078)	1,158,664	$ 21,788	(135,549)	$ (966,108)	30,985
Balance at end of period (in shares) at Jan. 29, 2022									80,074,914
Increase (Decrease) in Stockholders' Equity
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Net earnings	$ 161,544					149,610				11,934
Other comprehensive income (loss), net of income tax effect	3,208							1,476		1,732
Issuance of common stock under stock compensation plans including tax effect (in shares)			852,514						853,207
Issuance of common stock under stock compensation plans including income tax effect	591		$ 9	(10,076)					$ 10,658
Issuance of stock under Employee Stock Purchase Plan (in shares)			45,843						45,843
Issuance of stock under Employee Stock Purchase Plan	686			104					$ 582
Share-based compensation	20,395			20,334		61
Dividends	(53,266)					(53,266)
Share repurchases (in shares)			(8,985,603)						(8,985,603)
Share repurchases	(186,747)		$ (90)	90					$ (186,747)
Noncontrolling interest capital distributions	$ (6,013)									(6,013)
Balance at end of period (in shares) at Jan. 28, 2023	54,609,786		54,609,786
Balance at end of period at Jan. 28, 2023	$ 572,751		$ 546	532,398		1,276,857		(134,073)	$ (1,141,615)	38,638
Balance at end of period (in shares) at Jan. 28, 2023	88,161,467								88,161,467
Increase (Decrease) in Stockholders' Equity
Net earnings	$ 210,717					198,199				12,518
Other comprehensive income (loss), net of income tax effect	(182)							(2,937)		2,755
Issuance of common stock under stock compensation plans including tax effect (in shares)			1,513,392						1,513,330
Issuance of common stock under stock compensation plans including income tax effect	(1,214)		$ 16	(20,902)					$ 19,672
Issuance of stock under Employee Stock Purchase Plan (in shares)			38,127						38,127
Issuance of stock under Employee Stock Purchase Plan	617			119					$ 498
Share-based compensation	20,246			20,236		10
Dividends	(62,640)					(62,640)
Share repurchases (in shares)			(3,153,339)						(3,153,339)
Share repurchases	(64,081)		$ (32)	32					$ (64,081)
Purchase of redeemable noncontrolling interest	95			1,318						(1,223)
Noncontrolling interest capital distributions	(2,834)									(2,834)
Equity component value of convertible notes transactions, net	(726)			(726)
Sales of common stock warrants	25,921			25,921
Purchases of convertible note hedges	(40,092)			(40,092)
Reclassification of convertible bond hedges	68,530			68,530
Terminations of common stock warrants	(1,124)			(1,124)
Terminations of convertible note hedges	$ 8,810			8,810
Balance at end of period (in shares) at Feb. 03, 2024	53,007,966		53,007,966
Balance at end of period at Feb. 03, 2024	$ 734,794		$ 530	$ 594,520		$ 1,412,426		$ (137,010)	$ (1,185,526)	$ 49,854
Balance at end of period (in shares) at Feb. 03, 2024	89,763,349								89,763,349